South San Francisco, CA, United States of America

Zachary E R Newby

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Zachary E R Newby

Introduction

Zachary E R Newby is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for cancer treatment. With a total of three patents to his name, Newby is recognized for his innovative approach to addressing critical health challenges.

Latest Patents

Newby's latest patents focus on 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A (MAT2A) inhibitors. These compounds are designed to inhibit MAT2A, which plays a crucial role in various cancers, especially those characterized by reduced or absent methylthioadenosine phosphorylase (MTAP) activity. The patents disclose pharmaceutical compositions that comprise these derivatives and methods for treating diseases that can be addressed through MAT2A inhibition.

Career Highlights

Throughout his career, Newby has worked with notable companies, including Ideaya Biosciences, Inc. His work has been pivotal in advancing research and development in the pharmaceutical industry. His innovative contributions have the potential to impact cancer treatment significantly.

Collaborations

Newby has collaborated with professionals such as Muzaffar Alam and Leah Cleary. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field.

Conclusion

Zachary E R Newby is a prominent inventor whose work in developing MAT2A inhibitors showcases his commitment to advancing cancer treatment. His contributions to the pharmaceutical industry are noteworthy and reflect his dedication to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…